Mitsubishi UFJ Trust & Banking Corp Sells 10,890 Shares of Agilent Technologies, Inc. (NYSE:A)

Mitsubishi UFJ Trust & Banking Corp trimmed its holdings in Agilent Technologies, Inc. (NYSE:A) by 5.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 192,839 shares of the medical research company’s stock after selling 10,890 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned about 0.07% of Agilent Technologies worth $28,060,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the business. Livelsberger Financial Advisory purchased a new stake in Agilent Technologies in the 4th quarter valued at $26,000. MV Capital Management Inc. lifted its position in shares of Agilent Technologies by 120.7% during the 4th quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after buying an additional 105 shares in the last quarter. VisionPoint Advisory Group LLC bought a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $29,000. Rise Advisors LLC increased its position in shares of Agilent Technologies by 527.8% during the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after acquiring an additional 190 shares during the last quarter. Finally, YHB Investment Advisors Inc. bought a new stake in Agilent Technologies during the first quarter worth $34,000.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on A shares. Barclays decreased their target price on Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating for the company in a research report on Friday, May 31st. TD Cowen lowered their price objective on shares of Agilent Technologies from $163.00 to $153.00 and set a “buy” rating on the stock in a research report on Thursday, May 30th. Bank of America boosted their target price on shares of Agilent Technologies from $134.00 to $140.00 and gave the company a “neutral” rating in a research note on Tuesday, June 25th. Citigroup upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and raised their price target for the stock from $135.00 to $150.00 in a research note on Wednesday, July 10th. Finally, Wolfe Research downgraded Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $138.06.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the completion of the transaction, the chief executive officer now directly owns 25,185 shares in the company, valued at approximately $3,274,050. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the transaction, the senior vice president now owns 49,486 shares in the company, valued at $6,595,494.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $130.00, for a total value of $254,540.00. Following the sale, the chief executive officer now owns 25,185 shares of the company’s stock, valued at $3,274,050. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

Agilent Technologies stock traded down $0.19 during midday trading on Friday, reaching $131.78. 1,731,443 shares of the stock were exchanged, compared to its average volume of 2,258,323. Agilent Technologies, Inc. has a 52 week low of $96.80 and a 52 week high of $155.35. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15. The firm has a market cap of $38.45 billion, a PE ratio of 31.15, a PEG ratio of 4.47 and a beta of 1.05. The company’s fifty day moving average is $136.39 and its 200-day moving average is $137.49.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.19 by $0.03. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The firm had revenue of $1.57 billion for the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter in the prior year, the firm posted $1.27 earnings per share. The business’s quarterly revenue was down 8.4% on a year-over-year basis. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd will be given a $0.236 dividend. This represents a $0.94 annualized dividend and a dividend yield of 0.72%. The ex-dividend date of this dividend is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.